Product Images Desvenlafaxine

This text presents information related to renal and hepatic impairments, population description, gender, age, and PK (pharmacokinetics). The severity of renal and hepatic impairments is classified into four categories, including ESRD (End Stage Renal Disease). Additionally, this text includes a table with geometric mean ratios indicating the change relative to reference for parameters such as Cmax and AUC in PK studies.*

This text appears to be reporting on the results of a study that measured the effects of the drug ketoconazole on the pharmacokinetics (PK) of CYP3A4 inhibitors. The results are expressed as geometric mean ratios, with a 90% confidence interval provided for each. The text also includes specific data on changes in Cmax, AuC, and T values due to ketoconazole, as well as the relative change compared to a reference.*

The text describes a graph displaying the estimated proportion of patients with relapse and the time to relapse in days from randomization. The graph compares the performance of Desvenlafaxine 50mg with a Placebo. The X-axis of the graph represents time to relapse in days (ranging from 0 to 150 days), while the Y-axis represents the estimated proportion of patients with relapse (ranging from 0% to 100%).*

This is a package of Pristiq 25mg Tablets that have been prepackaged by Bryant Ranck. It can be compared to the same medication produced by West-Ward Columbus Inc. The package contains 30 tablets that expire on a certain month and year (MM/YY) and has an NDC number. The package should be stored between 20°C-25°C (68°F-77°F) at room temperature. The label also includes a warning to keep all drugs out of reach of children. The last line contains a series of numbers that may be a barcode or tracking code.*